|
Anemias
Citations 51-60 of 84 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Provision of Pneumococcal Prophylaxis for Publicly Insured Children With Sickle Cell Disease
- Colin M. Sox; William O. Cooper; Thomas D. Koepsell; David L. DiGiuseppe; Dimitri A. Christakis
JAMA 2003; 290: 1057-1061.
[Abstract]
[Full text]
[PDF]
- Letters
Long-term Use of Hydroxyurea for Sickle Cell Anemia
- Lawrence Feldman; Sandra Allen; Maxwell Westerman; Lori Feldman; Alice Gilman-Sachs; Kenneth Beaman
JAMA 2003; 290: 752-b-753-b.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Use of Hydroxyurea for Sickle Cell Anemia
- Derrick W. Spell
JAMA 2003; 290: 752-a.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Use of Hydroxyurea for Sickle Cell Anemia
- Dean Anthony Lee; Brigitta U. Mueller
JAMA 2003; 290: 753-a-754-a.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Use of Hydroxyurea for Sickle Cell Anemia
- Ward Hagar
JAMA 2003; 290: 753.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Use of Hydroxyurea for Sickle Cell Anemia—Reply
- Martin H. Steinberg; Franca Barton; Michael Terrin; Myron Waclawiw; Duane Bonds
JAMA 2003; 290: 754.
[Extract]
[Full text]
[PDF]
- Letters
Aplastic Anemia and Immunosuppression—Reply
- Neal S. Young; Stephen Rosenfeld
JAMA 2003; 290: 193-b.
[Extract]
[Full text]
[PDF]
- Letters
Aplastic Anemia and Immunosuppression
- Stephen M. Nagy Jr; John J. Fisher
JAMA 2003; 290: 193-a.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment
- Martin H. Steinberg; Franca Barton; Oswaldo Castro; Charles H. Pegelow; Samir K. Ballas; Abdullah Kutlar; Eugene Orringer; Rita Bellevue; Nancy Olivieri; James Eckman; Mala Varma; Gloria Ramirez; Brian Adler; Wally Smith; Timothy Carlos; Kenneth Ataga; Laura DeCastro; Carolyn Bigelow; Yogen Saunthararajah; Margaret Telfer; Elliott Vichinsky; Susan Claster; Susan Shurin; Kenneth Bridges; Myron Waclawiw; Duane Bonds; Michael Terrin
JAMA 2003; 289: 1645-1651.
[Abstract]
[Full text]
[PDF]
- Letters
Erythropoietin and Transfusions Among Critically Ill Patients
- Kevin C. Abbott
JAMA 2003; 289: 1511-a-1512-a.
[Extract]
[Full text]
[PDF]
|
|
